Preliminary falsification of EIA screening is cost-effective in the two-step serodiagnosis of Lyme disease [2] (multiple letters)

Abstract

Increasing attention is being paid to scientific aspects of policy or administrative decisions taken at a European level. Certain features of the process including the potentially irreversible consequences of decisions, the uncertainties involved, and the pressure on scientists to produce a particular result, indicate the need for a new relationship between science and governance. This should incorporate greater openness and more participation in the process from stakeholders. The European Commission is working to meet these requirements through the establishment of guidelines for applying the precautionary principle, the development of a European research area to integrate research at the European level with that in the Member States, and increased attention to the management and assessment of knowledge. © Oxford University Press 2001.